Skip to main content
. 2003 Dec;56(6):368–370. doi: 10.1136/mp.56.6.368

Figure 2.

Figure 2

Comparison of methods with clinical samples. (A) Gel of QIAamp method. (B) Gel of TaKaRa method. (C) Blot of QIAamp method. (D) Blot of TaKaRa method. M, molecular weight marker; lanes 1–5, clinical samples 1–5, respectively; lanes 6 and 7, negative controls.